Circulating tumor DNA detection after neoadjuvant treatment and surgery predicts recurrence in patients with early-stage and locally advanced rectal cancer

Autor: Lisa S.M. Hofste, Maartje J. Geerlings, Daniel von Rhein, Heidi Rütten, A. Helen Westenberg, Marjan M. Weiss, Christian Gilissen, Tom Hofste, Rachel S. van der Post, Bastiaan R. Klarenbeek, Johannes H.W. de Wilt, Marjolijn J.L. Ligtenberg, Linda Garms, Maite Liem, Tom Rozema, Dareczka Wasowicz, Pim Burger, Fatih Polat, Koen Reijnders, Marnix de Roos, Colin Sietses

Publikováno v: European Journal of Surgical Oncology, 49, 7, pp. 1283-1290
European Journal of Surgical Oncology. W.B. Saunders Ltd
Libic2 collaborators group 2023, ' Circulating tumor DNA detection after neoadjuvant treatment and surgery predicts recurrence in patients with early-stage and locally advanced rectal cancer ', European Journal of Surgical Oncology, vol. 49, no. 7, pp. 1283-1290 . https://doi.org/10.1016/j.ejso.2023.01.026
European Journal of Surgical Oncology, 49, 1283-1290

Contains fulltext : 293876.pdf (Publisher’s version ) (Open Access) INTRODUCTION: Patients with early-stage and locally advanced rectal cancer are often treated with neoadjuvant therapy followed by surgery or watch and wait. This study evaluated th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7f8cb825ea7668967bed64ce1263935
https://repository.ubn.ru.nl/handle/2066/293876

Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial

Autor: Madeleine T King, Emma K Link, Tim J Whelan, Ivo A Olivotto, Ian Kunkler, Antonia Helen Westenberg, Guenther Gruber, Penny Schofield, Boon H Chua, Claire Phillips, Guy Bryant, Helen Westenberg, Om Pra-Kesh Purohit, Verity Ahern, Peter Graham, Mohamed Akra, Orla McArdle, Peter O'Brien, Jane Ludbrook, Jennifer Harvey, John H Maduro, Isabelle Gabelle-Flandin, Carine Kirkove, Carolyn Bedi, Joseph Martin, Tony Vu, Theirry Muanza, Anthony Neal, Adel Courdi, Juliette Thariat, Eileen Rakovitch, Laurien Daniels, Marjan van Hezewijk, Wlasyslawa Cwajna, Adelheid Roelstraete, Angela van Baardwijk, Nicola Russel, Anne Koch, Jennifer Croke, Imogen Locke, Peter Jeal, Quenten Walker, Kandeepeepan Thuraisingham, Anupam Chauduri, David Joseph, Mandy Taylor, Sabine Vanderkam, Tony Woo, Johann Tang, Michael Yassa, Elaine Wai, Susan Hewitt, Shazia Mahmood, Jennifer Gilmore, Bolante Ofi, Amit Bahl, Olga Vujovic, Edward Yu, Duc Le, Iwa Kong, Alan Nichol, Nina Bijker, Geoff Delaney, Malcolm Feigen, Adeline Lim, Michael Chao, Margaret Latham, Hafiz Algurafi, Christoph Tausch, Eric Khoo, Sam Leung, Karen Taylor, Sasha Senthi, Andrea Stevens, Abhro Chaudhuri, Susan Cleator, Adrian Murray Brunt, Scott Babington, David Christie, Daniel Zwahlen, Ulrich Schratzenstaller, Laurence Masson, Nicola Storey, Eshwar Kumar, Liz Sherwin, Reinhilde Weytjens, Sharma Ravi, Patricia Lawton, Ruth Angell, Glenys Round, Angela Allen, Ziad Thotathil, Margaret Anthes, Christiane Reuter, Laura Pettit, Yvonne Zissiadis, Christine Elder, Antoinette Verbeek-de Kanter, Andree Lirette, Ludwig Plasswilm, David Spooner, Fiona Hoar, Islam Mohamed, Kristina Lossl, Vivienne Loo, Antonella Richetti, Tamasin Evans, Aisling Hennessy, Medhat El-Mallah, Marketa Skala, Raef Awad, Isabelle Germain, Carine Mitine, Hilde Van Parijs, Mark Churn, Nawaz Walji, Michael Francis, Karin Stellamans, Gunther Gruber, Giovanni Ivaldi, Abdulla Alhasso, Lizbeth Kenny, Ken Tiver, Matthew Griffin, Gillian Lamoury, Marco Trovo, Hafiz Algufarfi, Minjae Lah, Scott Carruthers, George Papadatos, Gabriel Paardekooper, Mojca Persic, Bernadette Lavery

Publikováno v: lancet oncology, 21(5), 685-698. Lancet Publishing Group

Summary Background BIG 3-07/TROG 07.01 is an international, multicentre, randomised, controlled, phase 3 trial evaluating tumour bed boost and hypofractionation in patients with non-low-risk ductal carcinoma in situ following breast-conserving surger

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b2e40b50103fe55279eb6cf533ad88c
https://doi.org/10.1016/s1470-2045(20)30085-1

International comparison of cosmetic outcomes of breast conserving surgery and radiation therapy for women with ductal carcinoma in situ of the breast

Autor: Peter Graham, Mohamed Akra, Emma Link, Boon Chua, Timothy J. Whelan, G. Bryant, Jennifer Harvey, J Ludbrook, Ivo A. Olivotto, Ian Campbell, Guenther Gruber, Kash Purohit, O. McArdle, Geoff P. Delaney, A. Helen Westenberg, Joseph Martin, John H. Maduro, Ian H. Kunkler, Claire Phillips, Verity Ahern, C. Kirkove

Publikováno v: Olivotto, I A, Link, E, Phillips, C, Whelan, T J, Bryant, G, Kunkler, I, Westenberg, H, Purohit, K, Ahern, V, H. Graham, P, Akra, M, McArdle, O, Ludbrook, J J, Harvey, J A, Maduro, J H, Kirkove, C, Gruber, G, Martin, J D, Campbell, I D & Delaney, G P & Chua, B H 2019, ' International comparison of cosmetic outcomes of breast conserving surgery and radiation therapy for women with ductal carcinoma in situ of the breast ', Radiotherapy and Oncology . https://doi.org/10.1016/j.radonc.2019.07.024
Radiotherapy and Oncology, 142, 180-185. ELSEVIER IRELAND LTD

Purpose: To assess the cosmetic impact of breast conserving surgery (BCS), whole breast irradiation (WBI) fractionation and tumour bed boost (TBB) use in a phase III trial for women with ductal carcinoma in situ (DCIS) of the breast. Materials and me

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68b666fc5cf437a6af83fe7a21bb4447
https://doi.org/10.1016/j.radonc.2019.07.024

Patient-reported outcomes in ductal carcinoma in situ: A systematic review

Autor: Christobel Saunders, G. Bruce Mann, Petrina Burnett, A. Helen Westenberg, Phyllis Butow, Andrew J. Spillane, Zoe Winters, Ivo A. Olivotto, Boon Chua, Madeleine King, Claudia Rutherford

Publikováno v: European journal of cancer (Oxford, England : 1990). 71

Ductal carcinoma in situ (DCIS) is a pre-invasive breast cancer with excellent prognosis but with potential adverse impacts of diagnosis and treatment on quality of life and other patient-reported outcomes (PROs). We undertook a systematic review to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d849122c57ee0e580613ba6e351afde0
https://pubmed.ncbi.nlm.nih.gov/27987454

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial

Autor: Yazid Belkacemi, Dominic A.X. Schinagl, Herman Rijna, A. Marinelli, Jean H. G. Klinkenbijl, Grard A. P. Nieuwenhuijzen, Jos W. S. Merkus, Carlo Messina, Marko Snoj, Marieke E. Straver, Willem H. Bouma, Nigel J Bundred, Thijs van Dalen, A. Helen Westenberg, Huub van der Mijle, Nicole Duez, P. Meijnen, Emiel J. Th. Rutgers, Patrick Petignat, Corneel Coens, Robert E. Mansel, Leen Slaets, Lorenzo Orzalesi, Sanne C. Veltkamp, Jan Bogaerts, Luigi Cataliotti, Peter W. de Graaf, Geertjan van Tienhoven, Cornelis J.H. van de Velde, M. Donker

Publikováno v: Lancet Oncology, 15, 1303-10
Lancet Oncology, 15, 12, pp. 1303-10
The Lancet Oncology, 15(12), 1303-1310
The Lancet Oncology, Vol. 15, No 12 (2014) pp. 1303-1310
lancet oncology, 15(12), 1303-1310. Lancet Publishing Group

Item does not contain fulltext BACKGROUND: If treatment of the axilla is indicated in patients with breast cancer who have a positive sentinel node, axillary lymph node dissection is the present standard. Although axillary lymph node dissection provi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53caae6015ff98251c49c7a028271756
http://hdl.handle.net/2066/139222